Pulmonary alveolar proteinosis – current and future therapeutical strategies
- 28 June 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 29 (5) , 465-474
Abstract
Purpose of review: We discuss the most recent advances in the treatment of pulmonary alveolar proteinosis (PAP), an ultra-rare syndrome. Recent findings: Whole lung lavage (WLL) remains the gold standard of treatment for PAP syndrome. For the autoimmune form, recent trials with inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) confirmed the efficacy in up to 70% of cases, especially under continuous administration. In patients with hereditary PAP with underlying GM-CSF receptor mutations, ex vivo autologous hematopoietic stem-cell gene therapy and transplantation of autologous ex vivo gene-corrected macrophages directly into the lungs are promising approaches. Summary: There are no drugs approved for PAP at present, but cause-based treatments such as GM-CSF augmentation and pulmonary macrophage transplantation are paving the way for targeted therapy for this complex syndrome.Keywords
This publication has 107 references indexed in Scilit:
- Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosisOrphanet Journal of Rare Diseases, 2013
- Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiencyBlood, 2011
- Hereditary Pulmonary Alveolar Proteinosis: Pathogenesis, Presentation, Diagnosis, and TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Inhaled Granulocyte/Macrophage–Colony Stimulating Factor as Therapy for Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Genetic Disorders of Surfactant DysfunctionPediatric and Developmental Pathology, 2009
- Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA Journal of Experimental Medicine, 2008
- Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1Journal of Experimental Medicine, 2008
- Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in JapanAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intoleranceThe Journal of Pediatrics, 2004
- Lung transplantation for treatment of infants with surfactant protein B deficiencyThe Journal of Pediatrics, 1997